𝔖 Bobbio Scriptorium
✦   LIBER   ✦

APC mutations are associated with increased bone mineral density in patients with familial adenomatous polyposis

✍ Scribed by Razvan L Miclea; Marcel Karperien; Alexandra M Langers; Els C Robanus-Maandag; Antoon van Lierop; Bernies van der Hiel; Marcel P Stokkel; Bart E Ballieux; Wilma Oostdijk; Jan M Wit; Hans F Vasen; Neveen A Hamdy

Publisher
American Society for Bone and Mineral Research
Year
2010
Tongue
English
Weight
444 KB
Volume
25
Category
Article
ISSN
0884-0431

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The canonical Wnt pathway plays a key regulatory role in osteoblastogenesis and bone mass acquisition through its main effector, β‐catenin. Adenomatous polyposis coli (APC) represents the key intracellular gatekeeper of β‐catenin turnover, and heterozygous germ‐line mutations in the APC gene cause familial adenomatous polyposis (FAP). Whether APC mutations affect bone mass has not been previously investigated. We conducted a cross‐sectional study evaluating skeletal status in FAP patients with a documented APC mutation. Twenty‐two FAP patients with a mean age of 42 years (54.5% women) were included in this study. Mean bone mineral density (BMD) Z‐scores were significantly increased above normal at all measured sites: lumbar spine (p < .01), total hip (p < .01), femoral neck (p < .05), and trochanter (p < .01). Z‐scores were +1 or greater in 14 patients (63.6%) and +2 or greater in 5 (22.7%). Mean values of bone turnover markers were within normal ranges. There was a significant positive correlation between procollagen type I N‐terminal propeptide (P1NP) and β‐crosslaps (β‐CTX) (r = 0.70, p < .001) and between these markers and sclerostin and BMD measurements. We demonstrate that FAP patients display a significantly higher than normal mean BMD compared with age‐ and sex‐matched healthy controls in the presence of a balanced bone turnover. Our data suggest a state of “controlled” activation of the Wnt signaling pathway in heterozygous carriers of APC mutations, most likely owing to upregulation of cytoplasmic β‐catenin levels. © 2010 American Society for Bone and Mineral Research.

📜 SIMILAR VOLUMES

APC germline mutations identified in Cze
APC germline mutations identified in Czech patients with familial adenomatous polyposis
✍ Milada Kohoutová; Jitka Štekrová; Václav Jirásek; Jan Kapras 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 2 views

## Communicated by Georgia Chenevix-Trench Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited predisposition to colorectal cancer, which is caused by germline mutations in the adenomatous polyposis coli (APC) gene. The APC mutations have been investigated in 46 Czech unrelat

Characterization of two novel adenomatou
Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP)
✍ Bharati Bapat; Terri Berk; Angela Mitri; Zane Cohen; Steven Gallinger; Hartley S 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

Patients with Familial Adenomatous Polyposis (FAP) manifest numerous colorectal adenomas as well as benign and malignant extra-colonic lesions. Adenomatous polyposis coli (APC) gene mutations are the underlying genetic defect in FAP. We analyzed germline D N A of 81 unrelated FAP patients and evalua

Mutation analysis of the adenomatous pol
Mutation analysis of the adenomatous polyposis coli (APC) gene in Danish patients with familial adenomatous polyposis (FAP)
✍ Marie Luise Bisgaard; RASMUS S. Ripa; Steffen Bülow 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

## Development of one hundred or more adenomas in the colon and rectum is diagnostic for the dominantly inherited, autosomal disease Familial Adenomatous Polyposis (FAP). It is possible to identify a mutation in the Adenomatous Polyposis Coli (APC) gene in approximately 80% of the patients, and alm

Analysis of somatic APC mutations in rar
Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli
✍ Hendrik Bläker; Christian Sutter; Martina Kadmon; Herwart F. Otto; Magnus von Kn 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

## Abstract Patients with familial adenomatous polyposis coli (FAP) carry heterozygous mutations of the __APC__ gene. At a young age, these patients develop multiple colorectal adenomas that consistently display a second somatic mutation in the remaining __APC__ wild‐type allele. Inactivation of AP

Mutation analysis of the adenomatous pol
Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer
✍ Clara Ruiz-Ponte; Ana Vega; Angel Carracedo; Francisco Barros 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

Germline mutations in the tumor-suppresor APC gene are associated with hereditary familial adenomatous polyposis (FAP) and somatic mutations are common in sporadic colorectal cancer. In this study, we report the identification of three novel germline mutations: 1682-1683insA, 3252-3253insAT, 3544A>T

Screening for mutations of the APC gene
Screening for mutations of the APC gene in 66 Italian familial adenomatous polyposis patients: Evidence for phenotypic differences in cases with and without identified mutation
✍ Monica Giarola; Lisa Stagi; Silvano Presciuttini; Patrizia Mondini; Maria T. Rad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 2 views

Germline mutations in the APC gene are responsible for familial adenomatous polyposis (FAP), a dominantly inherited syndrome characterized by the development of hundreds to thousands of polyps in the colon and in the rectum of affected individuals and by variable extracolonic manifestations (gastric